(Q41253312)

28 September 2017

title

Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer (English)

1 reference

28 September 2017

main subject

prostatic hypertrophy

1 reference

5

Schally AV

1 reference

28 September 2017

Kadar T

1

1 reference

28 September 2017

Ben-David M

series ordinal

2

1 reference

28 September 2017

Pontes JE

series ordinal

3

1 reference

28 September 2017

Fekete M

series ordinal

4

1 reference

28 September 2017

publication date

1 January 1988

1 reference

28 September 2017

1 reference

28 September 2017

volume

12

1 reference

28 September 2017

issue

4

1 reference

28 September 2017

page(s)

299-307

1 reference

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

28 September 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Effect of chronic administration of a highly potent LHRH agonist on prostate size and secretory function in geriatric dogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Suppressive effect of quinolinic acid and hippuric acid on bone marrow erythroid growth and lymphocyte blast formation in uremia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

D-Trp-6-luteinizing hormone-releasing hormone inhibits hyperprolactinemia in female rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Interaction of prolactin and testosterone in the human prostate

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Serum FSH, LH and prolactin in normal males and patients with prostatic diseases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Biochemical endocrinology of prostatic tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

The pathogenesis of benign prostatic hyperplasia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Specific Prolactin Binding Sites in the Prostate and Testis of Rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Effects of testosterone and prolactin on rat prostatic weight, 5alpha-reductase, and arginase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Micromethod for the determination of free and total prolactin receptors: measurement of receptor levels in normal and malignant mammary and prostate tissues

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

The presence of LHRH-like receptors in Dunning R3327H prostate tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Hormone blood levels in patients with prostatic carcinoma and their relation to the type of carcinoma growth differentiation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Effect of a GnRH analogue (leuprolide) on benign prostatic hypertrophy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Effect of long-term hyperprolactinemia on the prolactin receptor content of the rat ventral prostate.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Effects of hyperprolactinemia on the accessory sexual organs of the male rat

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Effects of prolactin on testosterone-induced growth and protein synthesis in rat accessory sex glands

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Gonadotropin-releasing hormone binding sites in human breast carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120403

Identifiers

DOI

10.1002/PROS.2990120403

1 reference

release_tdipdvqpyjfwrjxt7sridjbfl4

28 September 2017

Fatcat ID

1 reference

https://api.fatcat.wiki/v0/release/tdipdvqpyjfwrjxt7sridjbfl4

Fatcat

reference URL

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference